Gross-to-Net Accruals
Master Accurate and Automated Gross-to-Net Accrual Management
Automated gross-to-net accruals empowers pharmaceutical finance teams to make informed, educated business decisions, driving better visibility and product profitability.
Manual GTN Business Challenges
Pharmaceutical finance and market access teams face four critical business challenges – inefficiency and rework, risky manual process, financial statement errors, audit points & compliance issues – as they try to accurately accrue for the vast number of rebates, discounts, chargebacks, admin fees, copay programs, and other sales-related adjustments and incentives.
IntegriChain’s Gross-to-net (GTN) software is an end-to-end revenue solution for your market access and finance departments. Offered as Software-as-a-Service (SaaS), Business Process-as-a-Service (BPaaS), and hybrid operating models, our deployment options are flexible, scalable, auditable, and customizable to your business needs. By automating GTN, you can improve margins, reduce costs, mitigate risk, and drive business decisions based on actionable analytics.
High-Performance Design and Capabilities
The functionality of GTN Accruals is configured for all standard line items with robust out-of-the-box accrual methodologies including:
- Methodology library to calculate current month close accruals
- Prior period true-up functionality
- Inventory pipeline adjustments to accruals
- Balance sheet roll-forward and reconciliations
- Preconfigured reports and dashboards
Business Benefits Realized
- Quicker Close. Close books and forecasts in fewer days by reducing and eliminating manual data collection & calculations.
- Easier Audit. Built-in auditability, traceability, and scalability reduces audit prep time by up to 30%.
- More Secure Environment. Strong access, privacy, and security controls ensures a “single version of the truth” approach to data and calculations.
- More Accurate Accruals. Bottoms-up with transparency to details and consistency of models across businesses and brands.
- Deeper Insights and Decision Support. Advanced analytics and data visualization provide improved decision-making regarding brand-level profitability, price/volume analysis, and “what-if” scenario and price-change modeling.
- ‘Real-time’ Reporting. Partnership, brand, and product family-level reporting is available at your fingertips.
Part of the Larger GTN Solution
IntegriChain’s GTN Accruals solution is part of our broader GTN solution that delivers on four distinct types of capabilities:
Features of GTN Software:
- Integrated Data Mart
- Methodology Library
- Automated Data Cleansing
- Scalability & Auditability
- Payer Mix and Returns Analog Benchmarks
- Commercial Contracting and Government Regulation Expertise
- GTN What-if Analytics
- Sales/Demand/Inventory Harmonization
- SOC Certified Processes and Controls
- Project Accelerators
- Customer and Auditor Training
Interested in learning more?
Blog
5 Pharma Gross-To-Net Questions You Should Be Asking
Whether manufacturers are entering new therapeutic categories, exploring new indications for a current product, or looking to acquire a new product through acquisition, portfolio growth presents both opportunities and challenges.
Blog
Why Modernize Your Gross-To-Net?
5 Benefits of Pharma Digital Transformation
In the current pharmaceutical landscape, more than 80% of manufacturers still rely on manual processes to accrue, forecast, and report their gross-to-net (GTN) deductions. However, in the era of big data and technological enhancements, manual processes cannot be relied on forever.